|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investment securities available for sale, at fair value | ||||||||||||||||||||
| Residential loans, at fair value | ||||||||||||||||||||
| Residential loans | ||||||||||||||||||||
| VIE, Primary Beneficiary | ||||||||||||||||||||
| Total residential loans, at fair value | ||||||||||||||||||||
| Residential loans held for sale, at fair value | ||||||||||||||||||||
| Multi-family loans, at fair value | ||||||||||||||||||||
| Equity investments, at fair value | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Assets of disposal group held for sale | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| VIE, Primary Beneficiary | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Repurchase agreements and warehouse facilities | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Total repurchase agreements and warehouse facilities | ||||||||||||||||||||
| Collateralized debt obligations ($3,240,220 at fair value and $341,636 at amortized cost, net as of June 30, 2026 and $3,148,157 at fair value and $363,645 at amortized cost, net as of December 31, 2025) | ||||||||||||||||||||
| Collateralized Debt Obligations | ||||||||||||||||||||
| VIE, Primary Beneficiary | ||||||||||||||||||||
| Total collateralized debt obligations ($3,240,220 at fair value and $341,636 at amortized cost, net as of June 30, 2026 and $3,148,157 at fair value and $363,645 at amortized cost, net as of December 31, 2025) | ||||||||||||||||||||
| Senior unsecured notes ($347,537 at fair value as of June 30, 2026 and $260,852 at fair value and $99,585 at amortized cost, net as of December 31, 2025) | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Mortgages payable on real estate, net | ||||||||||||||||||||
| Liabilities of disposal group held for sale | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| VIE, Primary Beneficiary | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable Non-Controlling Interest in Consolidated Variable Interest Entities | ||||||||||||||||||||
| VIE, Primary Beneficiary | ||||||||||||||||||||
| Total redeemable Non-Controlling Interest in Consolidated Variable Interest Entities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share, 200,000,000 shares authorized, 22,385,674 shares issued and outstanding ($559,642 aggregate liquidation preference) | ||||||||||||||||||||
| Preferred Stock, Series Shares | ||||||||||||||||||||
| Total preferred stock, par value $0.01 per share, 200,000,000 shares authorized, 22,385,674 shares issued and outstanding ($559,642 aggregate liquidation preference) | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 200,000,000 shares authorized, 89,879,786 and 90,303,863 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Company's stockholders' equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| VIE, Primary Beneficiary | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
